CRH’s 9-month performance met our projections. Sales soared by 8%, accompanied by a 14% increase in EBITDA, leading to a 100bp rise in the EBITDA margin. Strong demand and robust pricing, notably in the American markets, buoyed this performance, countering the weaker conditions in Europe. CRH has marginally lifted its EBITDA forecast to $6.3 billion.
21 Nov 2023
9m 23: Price surge for short-term gain, acquisitions for long-term growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
9m 23: Price surge for short-term gain, acquisitions for long-term growth
CRH public limited company (CRH:LON) | 0 0 (-0.2%) | Mkt Cap: 43,165m
- Published:
21 Nov 2023 -
Author:
Loco Douza -
Pages:
3
CRH’s 9-month performance met our projections. Sales soared by 8%, accompanied by a 14% increase in EBITDA, leading to a 100bp rise in the EBITDA margin. Strong demand and robust pricing, notably in the American markets, buoyed this performance, countering the weaker conditions in Europe. CRH has marginally lifted its EBITDA forecast to $6.3 billion.